# Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

> **NCT06334731** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 400 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06334731
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-06
- **Primary completion:** 2025-07-14
- **Final completion:** 2025-07-14
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06334731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06334731, "Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06334731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*